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Abstract Staphylokinase (SAK) forms an inactive 1:1 complex
with plasminogen (PG), which requires both the conversion of
PG to plasmin (Pm) to expose an active site in PG^SAK
activator complex and the amino-terminal processing of SAK to
expose the positively charged (Lys-11) amino-terminus after
removal of the 10 N-terminal amino acid residues from the full
length protein. The mechanism by which the N-terminal segment
of SAK affects its PG activation capability was investigated by
generating SAK mutants, blocked in the native amino-terminal
processing site of SAK, and carrying an alteration in the
placement of the positively charged amino acid residue, Lys-11,
and further studying their interaction with PG, Pm, miniplasmin
and kringle structures. A ternary complex formation between
PG^SAK PG was observed when an immobilized PG^SAK
binary complex interacted with free radiolabelled PG in a
sandwich binding experiment. Formation of this ternary complex
was inhibited by a lysine analog, 6-aminocaproic acid (EACA),
in a concentration dependent manner, suggesting the involvement
of lysine binding site(s) in this process. In contrast, EACA did
not significantly affect the formation of binary complex formed
by native SAK or its mutant derivatives. Furthermore, the binary
(activator) complex formed between PG and SAK mutant,
PRM3, lacking the N-terminal lysine 11, exhibited 3^4-fold
reduced binding with PG, Pm or miniplasmin substrate during
ternary complex formation as compared to native SAK.
Additionally, activator complex formed with PRM3 failed to
activate miniplasminogen and exhibited highly diminished
activation of substrate PG. Protein binding studies indicated
that it has 3^5-fold reduction in ternary complex formation with
miniplasmin but not with the kringle structure. In aggregate,
these observations provide experimental evidence for the
participation of the N-terminal region of SAK in accession and
processing of substrate by the SAK^Pm activator complex to
potentiate the PG activation by enhancing and/or stabilizing the
interaction of free PG.
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1. Introduction
Staphylokinase (SAK), a pro¢brinolytic 16 kDa protein
secreted by several strains of Staphylococcus aureus, has re-
cently been identi¢ed as a potent ¢brin-selective plasminogen
(PG) activator [1^3] with immense therapeutic potential for
coronary thrombolysis in patients with acute myocardial in-
farction. It forms a 1:1 stoichiometric complex with PG or
plasmin (Pm) to generate an activator complex for the PG
activation [4^6] very similar to streptokinase (SK). However,
certain key di¡erences have been found in the basic mecha-
nism of PG activation by these two PG activators of bacterial
origin. In striking contrast with the PG^SK complex, the PG^
SAK complex remains inactive and requires conversion to the
SAK^Pm form to generate an active site displaying high spe-
ci¢city for the PG activation. Also, the generation of PG
activation potential in SAK proceeds via Pm-mediated remov-
al of the 10 amino-terminal amino acid residues [7]. The three-
dimensional structures of SAK and SAK^microplasmin com-
plex have recently been elucidated by X-ray di¡raction studies
[8,9], which indicated that the amino-terminus of SAK cover-
ing the ¢rst 17 amino acid residues acquires a £exible, disor-
dered structure and remains surface-exposed. It has been
shown that amino-terminal proteolysis of SAK to generate a
low molecular form of SAK is essential for the PG activation
and may occur in vivo presumably by traces of Pm. The low
molecular form of SAK, lacking its ¢rst 10 N-terminal amino
acid residues, carries full potential for its activation function
but its PG activation capability is signi¢cantly reduced when
Lys-11 is replaced with another amino acid residue or its
position is altered, indicating that Lys-11 plays a crucial
role in its protein function. Recent experimental evidences
suggest that the positively charged amino-terminal region of
SAK is obligatory for SAK to achieve full PG activation
potential in the enzyme complex formed between SAK and
Pm [7]. However, at this stage, a detailed understanding of the
molecular mechanism of its action is missing. The aim of this
study is to probe the role(s) of the amino-terminal region of
SAK in the PG activation process through site-directed muta-
genesis of the amino-terminal region of SAK and character-
ization of these mutants for their functional characteristics
during protein^protein interaction. In the present work, the
function of the amino-terminal region of SAK has been elu-
cidated by site-directed mutagenesis of the N-terminal pro-
cessing site of SAK and studying the interaction of these
SAK mutants during binary and ternary complex formation
in the process of PG activation.
2. Materials and methods
2.1. Bacterial strains, plasmids and reagents
S. aureus (local isolate, designated as SAK11) was used for retriev-
ing the gene (sak) encoding SAK. Plasmid vectors, Bluescript KS
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(Stratagene, Germany) and pET9b (Promega, WI, USA) were utilized
for cloning and gene expression purposes. All restriction and DNA
modifying enzymes were obtained from Promega (WI, USA) or New
England Biolabs (Beverly, USA). Lys-Sepharose, CNBr-activated
Sepharose CL-4B, DEAE-Sepharose CL-4B and phenyl-Sepharose
CL-4B were obtained from Pharmacia Biotech. Chromozyme PL and
human PG were purchased from Boehringer Mannheim (Germany).
2.2. Cloning and expression of recombinant SAK and its mutants in
Escherichia coli
The structural gene (sak), encoding SAK, was retrieved from the
genomic DNA of S. aureus (SAK11) through PCR ampli¢cation using
oligonucleotide primer pair (1) 5P-GATATATACATATGTCAAG-
TTCATTCGACAA-3P and (2) 5P-AAGCTTTCCACTTTTTATCC-
TAACTGATTTCTCCCCATAAGT-3P, designed on the basis of the
known nucleotide sequence of the sak gene [10], and it was cloned on
the plasmid vector Bluescript KS. The authenticity of the cloned
gene was established through nucleotide sequencing, which matched
perfectly with the published sak gene sequence [10]. Overexpression of
SAK in E. coli was achieved by cloning the sak gene on the expression
plasmid, pET9b, at the NdeI^BamHI site. For the cloning and expres-
sion of SAK mutants carrying an N-terminal modi¢cation, PCR
primers (1) 5P-GTAGCCATGAAAGGAGCATATGCAGCAGGA-
GAC-3 and (2) 5P-GTAGCCATGGCTGGAGATGACGCGAGT-3P
were utilized for the generation of SAK mutants, PRM2 and PRM3,
respectively. Incorporation of a mutation in the sak gene was con-
¢rmed by DNA sequencing.
2.3. Puri¢cation of recombinant SAK
For the production and puri¢cation of wild type or mutant SAK
proteins, the E. coli cells carrying recombinant plasmids for the ex-
pression of the respective target gene were induced with 1 mM IPTG
during mid log phase (OD600 = 0.6) and harvested after 7^10 h of
further incubation at 37‡C. The cells were collected after centrifuga-
tion and lysed either by sonication or through a French press. After
centrifugation of the cell lysate at 14,000 rpm, clear supernatant was
used for the recovery of SAK. A two step puri¢cation protocol in-
volving an ion-exchange (DEAE-Sepharose) and hydrophobic chro-
matography (phenyl-Sepharose) was utilized for obtaining a puri¢ed
protein preparation essentially as described previously [11]. The spe-
ci¢c functional activity of the puri¢ed preparation of recombinant
SAK was compared with a native protein preparation obtained
from S. aureus (a gift from Prof. Patrick J. Ga¡ney, WHO, UK)
which exhibited 160,000 U/mg of protein. The speci¢c PG-activating
capacity of the di¡erent SAK proteins was de¢ned as the amount of
Pm (Wmol) converted by 1 Wmol SAK protein from an excess of
human PG within 1 min. Therefore, 2.5 nM SAK was incubated
with 1.5 WM human PG in 0.1 M sodium phosphate, pH 7.4, at
37‡C for 30 min. The generation of Pm was followed by monitoring
the change in the absorbance at 405 nm/min caused by hydrolysis of
the synthetic Pm substrate chromozyme PL (Boehringer Mannheim,
Germany) used at a ¢nal concentration of 1 mM.
2.4. PG puri¢cation and miniPG preparation
Human PG was isolated from fresh frozen plasma using Lys-
Sepharose a⁄nity chromatography following the established proce-
dure [12]. Separation of the kringle structure (K1+K2+K3+K4) and
miniPG (kringle 5 and protease domain of PG) from the intact PG
was achieved by limited digestion of full length PG with pancreatic
elastase (Sigma) in 0.2 M Tris^Cl (pH 8.8) for 10 min at 37‡C using
the enzyme substrate ratio 1:100 as described elsewhere [13,14].
2.5. SAK assay and PG activation reaction
The speci¢c PG-activating activities of SAK and its mutants were
determined with a PG-coupled chromogenic assay [15]. Kinetic anal-
ysis of PG activation was done following the procedure of Arai et al.
[16] with slight modi¢cation. Brie£y, a mixture of PG (1.5 WM) and
SAK or its mutants (¢nal concentration 0.8 WM) was incubated at
37‡C for 5 min in 0.1 M phosphate bu¡er (pH 7.5) containing 0.1%
bovine serum albumin (BSA) and 0.01% Tween 80. The mixture was
diluted 10-fold and the change in absorption at 405 nm was recorded
at di¡erent time intervals after the addition of chromozyme PL. The
kinetic constants of PG activation were derived from Lineweaver^
Burk plots.
2.6. Casein^PG overlay
Bacterial colonies overexpressing SAK were detected by overlaying
a mixture of 0.8% agarose, 1% skim milk, 500 Wg human PG, 150 mM
NaCl and 50 mM Tris^Cl (pH 8.0) on top of the agar plates carrying
recombinant E. coli colonies as mentioned previously [17]. The plates
were incubated at 37‡C for 2^6 h. SAK positive colonies indicated a
clearing zone around the colonies. Zymographic analysis of the pro-
tein was done by separating the protein on SDS^PAGE (15%) and
placing the protein gel on top of the solidi¢ed agarose bed carrying a
mixture of casein (1%) and human PG (25 Wg/ml). The SAK protein
band was identi¢ed after the incubation of protein gel at 37‡C for 2^
6 h [17].
2.7. Sandwich binding assay
Formation of ternary complex between SAK and PG or its trun-
cated fragment carrying kringle domain or miniplasmin was checked
through sandwich binding assay as described by Young et al. [18] with
slight modi¢cation. Brie£y, 0.01^0.05 ml of PG (10 Wg/ml in 50 mM
Tris^Cl, pH 7.5) was immobilized on the nitrocellulose strips or mi-
crotiter plates, air-dried and blocked with 1% BSA for 1^2 h. Wild
type or mutant SAK was added in excess to the immobilized PG and
incubated for 30^60 min at 4‡C. Unbound SAK was removed after
washing with 0.05 M Tris^Cl (pH 7.4) containing 0.1% BSA and
0.01% Tween 80. Thereafter, 125I-labelled PG, miniPG or kringle
structures, at various concentrations, were added separately and in-
cubated further for another 30^60 min at 4‡C. Excess radioactivity
was removed through repeated washings with the same bu¡er and the
amount of labelled PG bound with the immobilized PG^SAK binary
complex was determined by the level of radioactivity incorporated
using a Q-counter. BSA was replaced with SAK to check the level
of non-speci¢c binding and the background was subtracted from the
total level to determine the speci¢c PG binding.
3. Results
3.1. Characteristics of SAK variants altered in N-terminal
processing (Lys-10^Lys-11) site
Cleavage of the Lys-10^Lys-11 peptide bond and exposure
of Lys-11 in the SAK moiety are the obligatory steps in the
SAK-mediated PG activation process. To unravel how this
e¡ect is manifested, site-directed mutants of SAK, altered in
its N-terminal processing site, were generated (Table 1).
PRM2 lacks its native N-terminal processing site (Lys-10-
Ala-Lys-11-Ala) but retains a lysine residue at the sixth posi-
tion. This mutation extends the length of the N-terminus by
Table 1
Characteristics of SAK mutants, altered in the N-terminal domain
Name N-terminal sequence of SAK variants Speci¢c activity (U/mg)
s
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
PRM1 (native SAK) S S S F D K G K Y K K G D D A 166,000
PRM2 M K G A Y A A G D D A 35,000
PRM3 M A G D D A 75,000
The arrow indicates the proteolysis site in SAK.
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four residues as compared to native SAK which gets pro-
cessed at Lys-11 after PG (Pm) binding [7]. The second
SAK mutant, PRM3 lacks its ¢rst 10 N-terminal residues
and Lys-11 was substituted with alanine (Table 1). Recombi-
nant SAK and its mutants were puri¢ed from E. coli,
BL21DE3, transformed with the respective plasmid con-
structs. PRM2 and PRM3 exhibited around 70% and 40%
reduction, respectively, in their functional activity as com-
pared to the native SAK (Table 1). Additionally, activation
of PG in the presence of PRM2 and PRM3 occurred slowly
with a marked lag phase as opposed to native SAK (PRM1)
where PG activation occurred exponentially with time (Fig.
1A). Zymographic analysis of SAK mutants exhibited the
similar pattern (data not presented). These results indicated
that PRM2 and PRM3 are signi¢cantly impaired in their ca-
pability of PG activation.
Cleavage of SAK at the Lys-10^Lys-11 junction exposes
Lys-11 in the processed SAK, which is an obligatory step
for the optimal function of SAK. Lysine analog, 6-aminocap-
roic acid (EACA), binds to PG via the lysine binding sites in
the kringle structure. Therefore, to check that the N-terminal
region of SAK mediates its e¡ect via interaction with the
lysine binding site, the pattern of PG activation by SAK
and its mutants (Fig. 1B^D) was studied in the presence of
varying amounts of EACA. Activation of PG in the presence
of SAK occurred progressively with a brief lag phase followed
by an exponential increase in PG activation. Under these ex-
perimental conditions, neither the PG nor SAK alone was
able to activate PG and generate Pm activity. In the presence
of EACA (10 mM), the PG activation rate via native SAK
(PRM1) was inhibited more than 60%. In contrast, a low
concentration of EACA (5 mM) increased PG activation twice
by PRM2 as compared to control (Fig. 1C). PRM3 exhibited
only marginal (10^20%) inhibition in the presence of EACA
(Fig. 1D). These observations provided the evidence that the
lysine binding site(s) resident in the kringle structure of PG
may be playing a crucial role in SAK-mediated PG activation.
3.2. Pattern of PG activation and SAK^PG binary complex
formation by SAK mutants
To evaluate that the impairment in PG activation capability
of SAK mutants, PRM2 and PRM3, is due to alteration in
their interaction with PG during the formation of SAK^PG
(Pm) activator (enzyme) complex and to check whether the N-
terminal lysine has any role in this process, the capability of
SAK and its mutants to generate complex with PG has been
Fig. 1. Pattern of PG activation by recombinant SAK and its mutants (A). E¡ect of EACA on PG activation by native SAK (B), PRM2 (C)
and PRM3 (D). Human PG (1.5 WM) was incubated with SAK or SAK mutants (0.5 WM) in the presence of 1.2 mM chromozyme PL at 25‡C
in 0.5 M Tris^Cl, 0.1 M NaCl (pH 7.4) containing 0.1% BSA and 0.01% Tween 80. The rate of Pm generation was followed by monitoring
the absorption at 405 nm at di¡erent time intervals. EACA at 5 and 10 nM concentrations was added in the reaction mixture to observe its ef-
fect.
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checked by studying the complex formation between radio-
labelled PG and SAK immobilized on nitrocellulose strips
or microtiter plates. The concentration dependent binding of
125I-labelled PG with SAK and its mutants was observed. Fig.
2A shows an increasing trend in the formation of SAK^PG
binary complex in a dose dependent manner. No binding of
125I-PG was observed when BSA was used in place of SAK. A
similar pattern of SAK^PG binary complex formation has
been observed by SAK variants, PRM2 and PRM3, indicating
that the alteration in the amino-terminal region of SAK does
not a¡ect the capability of SAK for the formation of activator
complex with PG. Addition of EACA did not exhibit any
signi¢cant e¡ect on the formation this binary complex of
PG with native or mutant SAK (Fig. 2B).
3.3. Substrate PG binding by the SAK^PG binary complex
Interaction of SAK^PG (Pm) enzyme complex with the free
substrate (PG), during PG activation, may form a transient
ternary structure in which two PG (Pm) molecules may asso-
ciate with one SAK moiety. A sandwich binding assay was
performed to compare the capability of ternary complex for-
mation with the activator complex formed with PG and wild
type SAK or its mutants, PRM2 and PRM3. In this experi-
ment, a varying amount of PG was coated on the microtiter
plate or immobilized on the nitrocellulose strips and then
allowed to react with the saturating amounts of native or
mutant SAK to develop a SAK^PG complex. Excess SAK
was removed by repeated washing. PG^SAK binary complex
thus created was then challenged with increasing amounts of
125I-labelled PG. The amount of 125I bound to a PG^SAK-
coated plate or nitrocellulose strips, which represented the
PG^SAK^PG ternary complex, was determined by measuring
the level of radioactivity incorporated (Fig. 3A). The level of
ternary complex formation increased with an increasing con-
centration of immobilized PG^SAK binary complex. Negli-
gible binding of labelled PG was observed when BSA was
used as a control in place of SAK. Immobilized SAK^PG
complex, formed with SAK mutants, PRM2, exhibited about
Fig. 2. Pattern of SAK^PG binary (activator) complex formation by
recombinant native SAK (PRM1) and its mutants (PRM2 and
PRM3) in the absence (A) and presence of EACA (B). Native or
mutant SAK proteins (1.5 ng) were immobilized on nitrocellulose
strips. Non-speci¢c protein binding sites were blocked with skim
milk (1%). Unbound proteins were removed by repeated washing
with 0.5 M Tris^Cl (pH 7.5) carrying 0.1% BSA and 0.01% Tween
80. Immobilized protein was probed with 125I-labelled human PG
and the level of PG binding was determined by a Q-counter. Each
binding result represents the mean of three independent determina-
tions.
Fig. 3. Formation of ternary complex (PG^SAK^PG) with substrate
PG by immobilized binary PG^SAK complex formed with native
SAK and its mutants in the absence (A) and presence of EACA
(B). Di¡erent concentrations of human PG were immobilized and
non-speci¢c sites were blocked as mentioned under Section 2. Native
or mutant SAK proteins were added (2 WM) to form binary com-
plex with the bound PG. After washing with 0.5 M Tris^Cl (pH
7.4) containing 0.1% BSA and 0.01% Tween 80, 125I-labelled PG (2^
3 WM) was added. Unbound PG was removed after repeated wash-
ing with the same bu¡er and the level of bound PG was determined
by a Q-counter.
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40% reduction in the interaction with the substrate PG in the
formation of ternary complex as compared to PRM1. The Km
values for the substrate PG binding by the preformed activa-
tor complex formed with PRM2 and PRM3 were 26 þ 2 WM
and 11 þ 1.8 WM, respectively, as compared to 3.4 þ 1.2 WM in
the case of native SAK suggesting 4^8-fold reduction in the
a⁄nity for the substrate PG in SAK mutants. These results
strongly indicated that structural features of the N-terminal
region of SAK are speci¢cally involved in the interaction of
SAK^Pm activator complex with substrate PG.
When radiolabelled PG was challenged with the binary
complex formed with PG and native SAK in the presence of
lysine analog, EACA (5 mM and 10 mM), the level of ternary
complex was signi¢cantly reduced as compared to control
(Fig. 3B). More than 50% reduction in the formation of ter-
nary complex has been observed in the presence of 10 mM
EACA. PRM2 exhibited a more or less similar pattern with
respect to substrate PG binding. In contrast, binary complex
formed with PG and PRM3, lacking N-terminal lysine, had
little e¡ect on the overall level of association with radiola-
belled PG. These observations suggested that interaction of
activator (binary complex between SAK^PG) complex with
the substrate (free) PG may involve kringle structure(s) carry-
ing lysine binding site(s) of PG and the N-terminal Lys-11
residue may play a crucial role in this process.
3.4. Interaction of the kringle structure (K1+K2+K3+K4) of
PG and miniplasmin with SAK^PG activator complex
Since the PG binding and activation pattern with native
and SAK mutants suggested the participation of the N-termi-
nal region of SAK and kringle structure of PG in the SAK-
mediated PG activation process, we evaluated the interaction
of kringle (K1+K2+K3+K4) and miniplasmin (K5+serine
protease domain), separately, with the activator complex
formed between PG and SAK or its mutants, PRM2 and
PRM3. The kringle structures were able to bind with SAK^
PG complex formed with the native or SAK mutant, PRM2,
with a more or less similar e⁄ciency. As opposed to native
SAK (PRM1) and PRM2, binary complex formed with PG
and PRM3 exhibited about 30% reduction in the formation of
ternary complex with kringle domain of PG (Fig. 4). Addi-
tionally, miniPG, carrying the protease domain of PG and
kringle 5, exhibited more than 50% reduction in the formation
of ternary complex with the immobilized PG^SAK enzyme
complex formed the SAK mutant, PRM3, as compared to
PRM2 and wild type (Fig. 4). These observations suggested
that the presence of N-terminal lysine might be important for
the interaction with the substrate PG probably through the
involvement of kringle 5. Although PRM2 interacts more or
less similar to that of wild type SAK, its PG activation capa-
bility is signi¢cantly reduced. It is probable that apart from
the N-terminal lysine residue, precise structural characteristics
of the N-terminal domain of SAK may also be required for its
optimal functioning. To further clarify the role of kringle
structures and the N-terminal region of SAK in the PG acti-
vation process, competition for binding between kringle struc-
ture, miniplasmin, and PG with the binary (enzyme) complex
formed with PG along with native SAK was checked. Both
kringle structures and miniplasmin compete e¡ectively with
intact PG for binding with PG^SAK binary complex, whereas
binding of kringles did not change signi¢cantly in the presence
of miniPG (Table 2). To further assess the functional role of
the amino-terminal region of SAK, the kinetics of PG and
miniPG activation by preformed activator complex, generated
by native SAK (PRM1) or its mutants (PRM2 and PRM3),
was examined. As compared to PG, progression of Pm gen-
eration was signi¢cantly slower when miniPG was used as a
substrate in the presence of the activator complex formed with
Pm and native SAK. The kinetic constants obtained for the
miniPG activation were about 3-fold higher (Km, 12.5 WM) as
Fig. 4. Formation of ternary complex by kringle structure (A) and
miniplasmin (B) by native and mutant SAK proteins. Binary com-
plex formed with PG and native SAK or its mutants (see Section 2)
was challenged with 2 ng of 125I-labelled kringle (K1+K2+K3+K4)
structure (A) and 2 ng of 125I-labelled miniplasmin (B) essentially as
described in Section 2 for the intact PG and binding of radiola-
belled protein was checked by a counter. Non-speci¢c binding was
determined using BSA (1 ng) and that level was subtracted from the
total binding to determine speci¢c binding of each protein.
Table 2
Interaction of binary complex formed with PG and native SAK or its mutants with various substrates
Substrates Percentage of 125I-labelled PG binding with SAK^PG binary
complex
PRM1 (native SAK) PRM2 PRM3
125I-PG 100 85 56
125I-PG+kringle (K1+K2+K3+K4) (2 WM) 64 59 28
125I-PG+kringle (K1+K2+K3+K4) (4 WM) 48 41 15
125I-PG+miniPG (2 WM) 71 67 48
125I-PG+miniPG (4 WM) 56 36 41
6^8 ng of human PG was immobilized on a microtiter or nitrocellulose strips and native (PRM1) or mutant SAK (PRM2, PRM3) protein was
added in excess individually and incubated for 3^4 h at 4‡C to develop a binary complex between SAK and PG. Excess SAK proteins were re-
moved by repeated washing with phosphate-bu¡ered saline containing 0.05% Tween 20. Competition between 125I-labelled PG and kringle
structure or miniplasmin to form a tertiary complex was determined by adding excess unlabelled kringle structure (20^40 ng) or miniplasmin
(40 ng) along with 125I-labelled PG.
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compared to the substrate PG (Km, 2.4 WM). These observa-
tions indicated a lower a⁄nity of miniPG for the SAK^Pm
activator complex as compared to the substrate PG. In the
presence of kringle structure (K1+K2+K3+K4, 4 WM), PG
activation decreased 20^30%, whereas a 10^15% increase in
miniPG activation was observed when activator complex
formed with PRM1 was utilized. Inhibition of PG activation
by kringle structure in the presence of preformed activator
complex clearly suggested that kringles are competing with
the substrate for the interaction/binding with the enzyme com-
plex but not with the miniPG. A slight increase in the activa-
tion of miniPG in the presence of kringle structure may be
due to better accessibility of enzyme complex to the miniPG
substrate as miniPG does not compete with kringle structure
for binding with the binary complex. Activation of PG or
miniPG substrate in the presence of enzyme complex formed
with PRM2 followed more or less a similar pattern (Fig. 5B)
although the e⁄ciency of PG or miniPG activation was rela-
tively less. In contrast, activator complex formed with PRM3
exhibited a highly diminished overall rate of miniPG activa-
tion, suggesting that the replacement of Lys-11 within the
N-terminus of SAK has adversely a¡ected the interaction of
enzyme complex with the miniplasmin substrate.
In aggregate, these observations suggested that the interac-
tion of miniplasmin and kringle structures with SAK^PG
complex may involve independent regions. Additionally, mini-
plasmin carrying kringle 5 of full length PG may have closer
interaction with the N-terminal region of SAK during PG
activation.
4. Discussion
The PG activation process via SAK involves several char-
acteristics including protein^protein interaction and complex
formation apart from proteolytic cleavage of SAK itself which
removes the ¢rst 10 N-terminal residues of the full length
SAK and exposes Lys-11 in the enzyme (SAK^PG/Pm) com-
plex [7,11]. In the present study, we have demonstrated that
the N-terminal regions of SAK modulate the interaction of
enzyme with substrate (free PG) but may not have any sig-
ni¢cant role in the formation of binary complex to generate
an initial enzyme complex consisting of SAK and PG. Sand-
wich binding assay, utilizing preformed immobilized enzyme
complex, and radiolabelled PG as a substrate, indicated the
formation of ternary complex in the form of PG^SAK^PG.
Inhibition of this ternary complex formation in the presence
of EACA suggested the involvement of the lysine binding
site(s) of kringle domain of PG in this process. These results
support the recent proposal that kringle domain of PG may
be involved in SAK-mediated PG activation [17].
Ten N-terminal residues of SAK are released during con-
version of inactive SAK^PG complex into catalytically active
SAK^Pm enzyme by hydrolysis of the Lys-10^Lys-11 peptide
bond of SAK. Presence of a Lys residue at the N-terminus of
SAK is required for achieving its full PG-activating potential
[7]. However, it is not yet clear whether proteolysis at this
precise position is necessary or occurred only because of sus-
ceptibility of this site for proteolytic processing. This problem
was addressed by generating two SAK mutants, one carrying
blockage in its native processing site at Lys-10^Lys-11, but
retaining its N-terminal lysine at the sixth N-terminal posi-
tion, and another lacking its 10 N-terminal residues as well as
Lys-11 substituted with alanine. SAK mutants, PRM2 and
PRM3, exhibit a signi¢cantly reduced PG activation capabil-
ity as compared to the native SAK. PRM2 carries blockage at
Lys-10^Lys-11 but retains a lysine residue at the sixth N-ter-
minal position. Its capability to form binary complex and
interact with the substrate PG compares well with native
Fig. 5. E¡ect of kringle structure on preformed Pm^SAK complex
catalyzed activation of PG and miniPG. Equimolar mixtures of PG
and SAK variants were preincubated for 5 min at 37‡C in 0.05 M
Tris^Cl (7.4), 0.1 M NaCl containing 0.0% BSA, 0.01% Tween 80
and 25% glycerol and then kept on ice. These preformed activator
complexes (¢nal concentration 20 nM) were then mixed with PG or
miniPG (10 WM), and generated Pm was measured at 405 nm in the
presence of chromogenic substrate chromozyme PL (1 mM).
(A) preformed complex with native SAK, PRM1, (B) PRM2 and
(C) PRM3.
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SAK. Since SAK mutant, PRM2, exhibits signi¢cant reduc-
tion in its PG activation capability, it is possible that increas-
ing the length of the N-terminal region of SAK by blocking its
native processing site at the Lys-10 residue inhibits full expo-
sure of functionally important residues of the enzyme complex
formed between SAK and PG (Pm) and thus a¡ects its PG
activation potential. The N-terminal region of SAK remains
unstructured and exhibits high conformational variability [7,8]
and recent nuclear magnetic resonance solution studies [19] on
SAK have indicated that the proteolytic cleavage of a 1^10
amino acid residue peptide from the full length SAK may
result in increased exposure to solvent of several regions of
the core of the SAK structure. Additionally, the three-dimen-
sional structure of SAK has indicated that the £exible N-ter-
minal region of SAK may form a loose association with the
functionally important region of SAK [8]. Thus, PRM2,
which has a four residue extension due to the blockage of
the native processing site at Lys-10^Lys-11 but retains a pos-
itively charged residue, Lys, at the sixth position may not fully
expose the functional region of SAK which in turn may a¡ect
the catalytic e⁄ciency of SAK^PG (Pm) enzyme complex. PG
binding studies have indicated that it interacts well with the
substrate PG or miniplasmin as compared to PRM3, which
lacks an N-terminal lysine. These observations suggested that
the removal of 10 amino acid residues of SAK may be essen-
tial for unmasking the functional core of SAK to expose its
full PG activation potential. It has been proposed [6] that the
exposed amino-terminal lysine of SAK may in£uence the ac-
tive site con¢guration of the enzyme complex via its K-amino
group. A precise conformation and length of the amino-ter-
minal region of SAK may be required for this process. Thus,
it is quite possible that the increase in the length of the N-
terminal region of SAK creates a less e¡ective active center
within the enzyme complex by shielding the functionally im-
portant region of enzyme complex.
In an attempt to study the functional role of the N-terminal
region of SAK, we investigated the interaction of various
substrates, e.g. PG, miniplasmin and kringle structure of
PG, with the enzyme complex formed with mutant SAK
and PG. Preformed binary complex generated with PG and
native SAK or its mutant, PRM2, carrying an N-terminal
lysine at the sixth position, interacts with radiolabelled sub-
strate PG with a more or less similar e⁄ciency. This interac-
tion is reduced signi¢cantly in the presence of lysine analog,
EACA. Moreover, activator complex formed with PG and
SAK mutant, PRM3, lacking N-terminal lysine and its ¢rst
10 N-terminal residues, interacts with the substrate PG with a
much lower e⁄ciency. The presence of lysine residue within
the N-terminal region of SAK improves the capability of the
enzyme complex, formed between SAK^PG, to interact with
the substrate. It has been proposed that the N-terminal region
of SAK must be located near the active site of Pm (in the PG^
(Pm)^SAK complex) to allow the initial cleavage of SAK at
Lys-10 [7,8]. This step may bring several changes in the en-
zyme complex such as exposure of functionally important
residues and reconformation of the active site with altered
substrate speci¢city. It is possible that these changes within
the SAK^PG binary complex may provide enhanced binding
and stabilization of substrate PG, resulting in e⁄cient conver-
sion of PG into Pm. Cocrystallization of SAK and microplas-
min complex and modeling of microplasmin and SAK struc-
ture have suggested [8] that a newly created N-terminal region
of SAK after Lys-10^Lys-11 peptide bond cleavage extends
away from the compact ellipsoid structure, running along a
depression between the enzyme and the substrate and may
interact with the lysine binding site of kringle 5 of a miniplas-
min substrate assisting in the ¢xation of PG substrate. Our
observations are in line with the proposed hypothesis and
demonstrate that SAK with a terminal lysine residue can in-
teract better with the substrate PG in contrast to the mutant
SAK lacking N-terminal lysine. Sandwich binding studies uti-
lizing preformed PG^SAK complex and free PG substrate
have clearly indicated that SAK mutant, PRM3, lacking N-
terminal lysine forms ternary complex with the substrate PG
with less e⁄ciency as compared to native SAK or SAK mu-
tant carrying lysine at the sixth N-terminal position. Compe-
tition studies involving interaction of miniplasmin and kringle
structure of PG with SAK^PG complex have demonstrated
that kringle domain of PG (1^4) and miniplasmin interact
independently with the SAK^PG (Pm) enzyme complex.
A role of the amino-terminal region of SAK in achieving
proper interaction with the substrate PG has been suggested
on the basis of the present study for the PG activation process
via native and mutant SAK. This interaction may stabilize the
enzyme (SAK^PG (Pm))^substrate (free PG) directly through
N-terminal lysine (Lys-11) via one of the lysine binding sites
present within the substrate PG. Since kringle 5 of PG resides
close to the protease domain of PG in the microplasmin form,
it is probable that the N-terminal arm of SAK interacts with
K5 via its N-terminal lysine and modulates the interaction of
substrate PG. This proposition is consistent with the recent
prediction through modeling of SAK with that of microplas-
min [8]. Alternatively, removal of 10 amino-terminal residues
from the N-terminus of SAK with an exposed Lys residue
may recon¢gure the enzyme complex and generate an e⁄cient
active center which interacts better with the substrate and
stabilizes the enzyme substrate complex during PG activation
via SAK.
Acknowledgements: We express our thanks to Dr. Girish Varshney,
for his help in radiolabelling of proteins, helpful suggestions and Ms.
Ramandeep for her help in preparation of this manuscript. Financial
support provided by CSIR, Govt. of India, is thankfully acknowl-
edged.
References
[1] Collen, D., De Cock, F., Vanlinthout, I., Declerck, P.J., Lijnen,
H.R. and Stassen, J.M. (1992) Fibrinolysis 6, 232^242.
[2] Collen, D., De Cock, F. and Stassen, J.M. (1993) Circulation 87,
996^1006.
[3] Lijnen, H.R. and Collen, D. (1996) Fibrinolysis 10, 119^126.
[4] Collen, D., Schlott, B., Engelborghs, Y., Van Hoef, B., Hart-
mann, M., Lijnen, H.R. and Behnke, D. (1993) J. Biol. Chem.
268, 8284^8289.
[5] Lijnen, H.R., Van Hoef, B., De Cock, F., Okada, K., Ueshima,
S., Matsuo, O. and Collen, D. (1991) J. Biol. Chem. 266, 11826^
11832.
[6] Lijnen, H.R., De Cock, F., Van Hoef, B., Schlott, B. and Collen,
D. (1994) Eur. J. Biochem. 224, 143^149.
[7] Schlott, B., Guhrs, K.H., Hartmann, M., Rocker, A. and Collen,
D. (1997) J. Biol. Chem. 272, 6067^6072.
[8] Rabijns, A., De Bondt, H.L. and De Ranter, C. (1997) Nat.
Struct. Biol. 4, 357^360.
[9] Parry, M.A., Fernandez-Catala, C., Bergner, A., Huber, R.,
Hopfner, K.P., Scholott, B., Guhrs, K.H. and Bode, W. (1998)
Nat. Struct. Biol. 5, 917^923.
[10] Sako, T. and Tsuchida, N. (1983) Nucleic Acids Res. 11, 7679^
7693.
FEBS 23706 25-5-00
G. Rajamohan, K.L. Dikshit/FEBS Letters 474 (2000) 151^158 157
[11] Schlott, B., Hartmann, M., Guhrs, K.H., Hirschfeld, E.B., Pohl,
H.D., Vanderschueren, S., Van de Werf, F., Michoel, A., Collen,
D. and Behnke, D. (1994) Bio/Technology 12, 185^189.
[12] Deutsch, D.G. and Mertz, E.T. (1970) Science 170, 1095^1096.
[13] Sottrup-Jenson, L., Claeys, H., Zajdel, M., Petersen, T.E and
Magnusson, S. (1977) in: Progress in Chemical Fibrinolysis and
Thrombolysis (Davidson, J.F., Rowan, R.M, Samama, M. and
Desnoyers, P.C., Eds.), Vol. 3, pp. 191^209, Raven Press, New
York.
[14] Shi, G.Y. and Wu, H.L. (1988) J. Biol. Chem. 263, 17071^17075.
[15] Lijnen, H.R., Van Hoef, B. and Collen, D. (1993) Eur. J. Bio-
chem. 211, 91^97.
[16] Arai, K., Madoiwa, S., Mimuro, J., Asakura, S., Matsuda, M.,
Sako, T. and Sakata, Y. (1998) J. Biochem. 123, 71^77.
[17] Pratap, J., Kaur, J., RajaMohan, G., Singh, D. and Dikshit, K.L.
(1996) Biochem. Biophys. Res. Commun. 227, 303^310.
[18] Young, K.C., Shi, G.Y., Wu, D.H., Chang, L.C., Chang, B.I.,
Ou, C.P. and Wu, H.L. (1998) J. Biol. Chem. 273, 3110^3116.
[19] Ohlenschlager, O., Ramachandran, R., Guhrs, K.H., Schlott, B.
and Brown, L.R. (1998) Biochemistry 37, 10635^10642.
FEBS 23706 25-5-00
G. Rajamohan, K.L. Dikshit/FEBS Letters 474 (2000) 151^158158
